Ledger.Open graph →
SEC Form D · filed September 17, 2015

Coherus BioSciences, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
REDWOOD CITY, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Peter K. Watler, Ph.D · Redwood City, CAExecDennis M. Lanfear · Redwood City, CAExec · DirectorMary T. Szela · Redwood City, CADirectorBarbara K. Finck, M.D · Redwood City, CAExecAlan C. Herman · Redwood City, CAExecAli J. Satvat · Menlo Park, CADirectorMats J. Wahlstrom · Denver, CODirectorChristos B. Richards · Los Angeles, CADirectorJames I. Healy, M.D., Ph.D · Menlo Park, CADirectorJoseph Hanna · Charleston, SCExecKim E. Armor · Washington, Washington, D.C.ExecDecca Guilherme · Red Bank, NJDirectorC. R. Allen · Washington, Washington, D.C.DirectorJean-Frederic J. Viret, Ph.D · Redwood City, CAExecAugust J. Troendle, M.D · Chincinnati, OHDirectorV. B. Lawlis, Ph.D · Redwood City, CADirectorHenri-Claude S. Bailly · Boston, MAExec · DirectorDavid E. Martirano · Boston, MADirectorZaid Ashai · Boston, MADirectorJames S. Eisenstein · Boston, MAExecRobert E. Pantano · Boston, MAExec · DirectorNeal Heble · Philadelphia, PADirectorJessica Marion · New York, NYDirectorJacques Nasser · Philadelphia, PAExecDavid Han · New York, NYDirectorJean-Frederic J. Viret, Ph.D · Redwood City, CAExecAugust J. Troendle, M.D · Cincinnati, OHDirectorV. B. Lawlis, Ph.D · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗